The Comparative Effectiveness of First-Line Tumor Necrosis Factor Inhibitor (TNFi) Compared with Non-TNFi Agents in Patients with Rheumatoid Arthritis: Results from the Corrona Registry

被引：0
|
作者：
Pappas, Dimitrios A. [1 ]
St John, Gregory [2 ]
Etzel, Carol J. [1 ]
Fiore, Stefano [3 ]
Blachley, Taylor [1 ]
Kimura, Toshio [2 ]
Punekar, Rajeshwari [3 ]
Emeanuru, Kelechi [1 ]
Boklage, Susan [2 ]
Kremer, Joel [1 ,4 ,5 ]
机构：
[1] Corrona LLC, Waltham, MA USA
[2] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA
[3] Sanofi, Bridgewater, NJ USA
[4] Albany Med Coll, Albany, NY 12208 USA
[5] Ctr Rheumatol, Albany, NY USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2018年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2877
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Adherence Patterns in Rheumatoid Arthritis Patients Receiving a Janus Kinase (JAK) Inhibitor or a Tumor Necrosis Factor a Inhibitor (TNFi) After the Addition of a Black Box Warning to JAK Inhibitors
    Rutter, W. Cliff
    Patel, Kunal
    Delgado, Samantha
    Cozzi, Guy
    Avalos-Reyes, Elisea
    Cavers, Will
    Liu, Chen
    Grover, Rashmi
    Feczko, Lucia
    Johnson, Kjel
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4228 - 4229
  • [42] Comparative effectiveness and safety of rituximab versus subsequent anti-tumor necrosis factor therapy in patients with rheumatoid arthritis with prior exposure to anti-tumor necrosis factor therapies in the United States Corrona registry
    Harrold, Leslie R.
    Reed, George W.
    Magner, Robert
    Shewade, Ashwini
    John, Ani
    Greenberg, Jeffrey D.
    Kremer, Joel M.
    ARTHRITIS RESEARCH & THERAPY, 2015, 17
  • [43] FIRST-LINE TUMOUR NECROSIS FACTOR INHIBITOR (TNFI) TREATMENT IS ASSOCIATED WITH HIGH MULTI-CRITERIA REMISSION EARLY ON COMPARED TO TREAT-TO-TARGET IN A TREATMENT NAIVE RA COHORT
    Shukla, Rudresh
    Plant, Darren
    Emery, Paul
    Buch, Maya H.
    RHEUMATOLOGY, 2023, 62
  • [44] A comparative effectiveness study of adalimumab, etanercept and infliximab in biologically naive and switched rheumatoid arthritis patients: results from the US CORRONA registry
    Greenberg, Jeffrey D.
    Reed, George
    Decktor, Dennis
    Harrold, Leslie
    Furst, Daniel
    Gibofsky, Allan
    DeHoratius, Ralph
    Kishimoto, Mitsumasa
    Kremer, Joel M.
    ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (07) : 1134 - 1142
  • [45] Effectiveness of a Second Biologic After Failure of a Non-tumor Necrosis Factor Inhibitor As First Biologic in Rheumatoid Arthritis
    Chatzidionysiou, Katerina
    Hetland, Merete Lund
    Frisell, Thomas
    Di Giuseppe, Daniela
    Hellgren, Karin
    Glintborg, Bente
    Nordstrom, Dan
    Peltomaa, Ritva
    Aaltonen, Kalle
    Trokovic, Nina
    Kristianslund, Eirik K.
    Kvien, Tore K.
    Provan, Sella A.
    Gudbjornsson, Bjorn
    Grondal, Gerdur
    Dreyer, Lene
    Kristensen, Lars Erik
    Jorgensen, Tanja Schjodt
    Jacobsson, Lennart T. H.
    Askling, Johan
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (10) : 1512 - 1518
  • [46] Comparative Long-Term Effectiveness of Switching to Another Tumour Necrosis Factor Antagonists, Tocilizumab or Rituximab in Patients with Rheumatoid Arthritis and Inadequate Response to a First-Line TNF Inhibitor
    Faria, Daniela Santos
    Eusebio, Monica
    Silva, Ioana Leite
    Rodrigues, Joana Ramos
    Neves, Joana Sousa
    Duarte, Ana Catarina
    Lopes, Carina
    Valido, Ana
    Dinis, Joana
    Freitas, Joao
    Santiago, Mariana
    Ferreira, Raquel
    Ganhao, Sara
    Miranda, Luis Cunha
    Peixoto, Daniela
    Teixeira, Filipa
    Alcino, Sergio
    Afonso, Carmo
    Costa, Jose Tavares
    Santos, Maria Jose
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [47] EFFECTIVENESS AND PERSISTENCE OF THE FIRST TUMOR NECROSIS FACTOR INHIBITOR IN PORTUGUESE PSORIATIC ARTHRITIS PATIENTS
    Vieira-Sousa, E.
    Eusebio, M.
    Avila-Ribeiro, P.
    Khmelinskii, N.
    Machado, R.
    Rocha, T. M.
    Bernardes, M.
    Santos-Faria, D.
    Leite Silva, J.
    Santos, H.
    Miguel, G.
    Carvalho, P.
    Costa, T.
    Teixeira, L.
    Meirinhos, T.
    Nero, P.
    Santos, M. J.
    VALUE IN HEALTH, 2017, 20 (09) : A527 - A527
  • [48] Treatment Decisions Following Diagnosis of Cancer during TNFi Inhibitor Treatment in Patients with Rheumatoid Arthritis: Results from the BSRBR-RA
    Druce, Katie
    Decock, Diederik
    Watson, Kath
    Symmons, Deborah P. M.
    Hyrich, Kimme L.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [49] Effectiveness Of TNF-a Inhibitor Therapy Does Not Differ Between Elderly and Younger Patients With Rheumatoid Arthritis: Results From The Corrona Registry.
    Hopkins, Aviva C.
    Martinez-Marti, Melisa
    Reed, George W.
    He, Ping
    Greenberg, Jeffrey D.
    Lozada, Carlos J.
    Pala, Ozlem
    Kremer, Joel M.
    Pappas, Dimitrios A.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S608 - S608
  • [50] COMPARATIVE EFFECTIVENESS OF BIOLOGIC AGENTS FOR PATIENTS WITH RHEUMATOID ARTHRITIS - PRIMARY ANALYSIS FROM THE US CORRONA CERTAIN STUDY
    Pappas, D. A.
    John, A.
    Kremer, J. M.
    Reed, G. W.
    Sommers, T.
    Greenberg, J. D.
    Curtis, J. R.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1020 - 1020
12345